Skuldtech, AB Science to Develop CDx for Pancreatic Cancer Drug | GenomeWeb

NEW YORK (GenomeWeb News) – Based on a new set of blood biomarkers, diagnostic development firm Skuldtech and pharma firm AB Science today said they plan to develop a companion diagnostic test for a molecule from AB Science for treating pancreatic cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.